The purpose of the Behavioral Assessment core (BAC) is to document neurobehavioral manifestations present in murine and rhesus monkey animal models which reflect pathological changes reminiscent of those seen in HIV+ patients, relevant, state of the art assays will target behaviors known to be impaired in patients with NeuroAids and associated with affected brain regions. To fulfill this goal the BAC will provide services for 1) demonstrating that viral disease models produce functional changes reflected in behavioral pathology, and 2) evaluating the therapeutic potential for novel agents using behavioral endpoints. The availability of the BAC will permit Scripps NeuroAIDS Preclinical Studies (SNAPS) PI's to obtain behavioral assays of animal models and target compounds using a novel level of analysis that has clinical relevance for the study of NeuroAIDS.
Specific Aims of the BAC are to provide behavioral testing in mouse models of viral pathogenesis including 1) Basic physiological measures, 2) Motor ability and exploration, 3) Learning and memory function, and in SIV-infected macaques, 4) Psychomotor performance, 5) Scheduled-controlled responding, 6) Complex, cognition assessed using tested based on a human battery. Additionally the BAC will be involved in 7) Behavioral analysis of novel compounds, 8) Advice and training for behavioral assessment, and 9) Close interactions with the other cores for education, outreach and collaborative activities of the CSPAR. The BAC is designed to be flexible according to the outreach and collaborative activities of the CSPAR. The BAC is designed to be flexible according to the strategic needs and priorities for the entire CSPAR set by the CSPAR Director, PI's, and the advisory boards. The BAC will solicit advice from these individuals regarding core policies, services and maintenance of collaborations among the BAC, other research cores, and potential new users. The Core director will communicate with SNAPS PI's to determine their current and future expectations for BAC services in order to ensure state of the art services that meet the needs of the CSPAR. Performance and output of the BAC will be evaluated by the efficient and timely acquisition of data leading to high quality publications and by the development of new projects related to work conducted by the Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
1P30MH062261-01
Application #
6221860
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2000-09-30
Project End
2005-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Sathyanesan, Monica; Watt, Michael J; Haiar, Jacob M et al. (2018) Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus. Transl Psychiatry 8:113
Zhou, Tian; Su, Hang; Dash, Prasanta et al. (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53-65
Thangaraj, Annadurai; Periyasamy, Palsamy; Liao, Ke et al. (2018) HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy. Autophagy 14:1596-1619
Kevadiya, Bhavesh D; Ottemann, Brendan M; Thomas, Midhun Ben et al. (2018) Neurotheranostics as personalized medicines. Adv Drug Deliv Rev :
Wiesman, Alex I; O'Neill, Jennifer; Mills, Mackenzie S et al. (2018) Aberrant occipital dynamics differentiate HIV-infected patients with and without cognitive impairment. Brain 141:1678-1690
Periyasamy, Palsamy; Thangaraj, Annadurai; Guo, Ming-Lei et al. (2018) Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis. J Neurosci 38:5367-5383
Zhou, Tian; Lin, Zhiyi; Puligujja, Pavan et al. (2018) Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. Nanomedicine (Lond) 13:871-885
Yang, Lu; Niu, Fang; Yao, Honghong et al. (2018) Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration. J Neuroimmune Pharmacol 13:330-344
Lin, Zhiyi; Gautam, Nagsen; Alnouti, Yazen et al. (2018) ProTide generated long-acting abacavir nanoformulations. Chem Commun (Camb) 54:8371-8374
McMillan, JoEllyn; Szlachetka, Adam; Zhou, Tian et al. (2018) Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS :

Showing the most recent 10 out of 374 publications